SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 41.69 |
Enterprise Value ($M) | -102.69 |
Book Value ($M) | 140.50 |
Book Value / Share | 8.16 |
Price / Book | 0.30 |
NCAV ($M) | 124.03 |
NCAV / Share | 7.20 |
Price / NCAV | 0.34 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.85 |
Return on Assets (ROA) | -0.49 |
Return on Equity (ROE) | -0.55 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.34 |
Current Ratio | 5.34 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 152.93 |
Assets | 169.39 |
Liabilities | 28.89 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -138.26 |
Net Income | -128.51 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -128.54 |
Cash from Investing | -25.33 |
Cash from Financing | 0.20 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Soleus Capital Master Fund, L.P. | 6.30 | ||
13G/A | Armistice Capital, Llc | 9.96 | 0.00 | |
13G/A | Acorn Bioventures, L.p. | 7.60 | ||
13G | Solas Capital Management, LLC | 7.40 | ||
13G/A | Vanguard Group Inc | 4.90 | 0.00 | |
13G/A | Westfield Capital Management Co Lp | 0.00 | -100.00 | |
13G/A | BlackRock, Inc. | 2.00 | -70.79 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,515,998 | 5,210,033 | 29.10 | |
1,447,272 | 6,501,855 | 22.26 | |
79,781,295 | 207,512,346 | 38.45 | |
67,845 | 215,019 | 31.55 | |
(click for more detail) |
Similar Companies | |
---|---|
MNKD – MannKind Corporation | MNOV – MediciNova, Inc. |
MRUS – Merus N.V. | NAII – Natural Alternatives International, Inc. |
NAMS – NewAmsterdam Pharma Company N.V. |
Financial data and stock pages provided by
Fintel.io